You are here

  • Home
  • Archive
  • Volume 106, Issue 7
  • Efficacy and safety of brolucizumab versus aflibercept in eyes with polypoidal choroidal vasculopathy in Japanese participants of HAWK

Article metrics

Article menu
Clinical science
Efficacy and safety of brolucizumab versus aflibercept in eyes with polypoidal choroidal vasculopathy in Japanese participants of HAWK

 

Online download statistics by month:

Online download statistics by month: July 2021 to October 2024

AbstractFullPdf
Jul 202111611154697
Aug 2021231223171784
Sep 2021172517231329
Oct 2021435418150
Nov 2021320310143
Dec 202126025485
Jan 202219319668
Feb 202225125166
Mar 202228127877
Apr 2022301297122
May 2022349340131
Jun 2022653651131
Jul 2022563549113
Aug 202254853692
Sep 202220819680
Oct 202220620485
Nov 2022201193103
Dec 202214513255
Jan 202311811560
Feb 202314013341
Mar 202314614059
Apr 202311811668
May 202312311179
Jun 202313313173
Jul 202312110949
Aug 2023716325
Sep 202311910334
Oct 202311010642
Nov 2023767235
Dec 2023836928
Jan 2024786542
Feb 202418117039
Mar 202413012778
Apr 2024554541
May 2024665638
Jun 202410910341
Jul 202417016031
Aug 202415915729
Sep 202411711134
Oct 2024747238
Total12609123336315